United States Recombinant Antibody Market Research Report Forecast 2017-2021
The United States Recombinant Antibody Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Recombinant Antibody industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Recombinant Antibody market study provides comprehensive data which enhances the understanding, scope and application of this report.
This report provides comprehensive analysis of
A.G.Scientific
Abbott Diagnostics
Agilent Technologies
BD Biosciences
Beckman Coulter
bioMerieux
Bio-Rad Laboratories
F. Hoffmann-La Roche
Gallus Immunotech
United States Recombinant Antibody Market: Product Segment Analysis
Type 1
Type 2
Type 3
United States Recombinant Antibody Market: Application Segment Analysis
Application 1
Application 2
Application 3
Reasons for Buying this Report
This report provides comprehensive analysis of
- Key market segments and sub-segments
- Evolving market trends and dynamics
- Changing supply and demand scenarios
- Quantifying market opportunities through market sizing and market forecasting
- Tracking current trends/opportunities/challenges
- Competitive insights
- Opportunity mapping in terms of technological breakthroughs
A.G.Scientific
Abbott Diagnostics
Agilent Technologies
BD Biosciences
Beckman Coulter
bioMerieux
Bio-Rad Laboratories
F. Hoffmann-La Roche
Gallus Immunotech
United States Recombinant Antibody Market: Product Segment Analysis
Type 1
Type 2
Type 3
United States Recombinant Antibody Market: Application Segment Analysis
Application 1
Application 2
Application 3
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a six-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
CHAPTER 1 RECOMBINANT ANTIBODY MARKET OVERVIEW
1.1 Product Overview and Scope of Recombinant Antibody
1.2 Recombinant Antibody Market Segmentation by Type
1.2.1 United States Production Market Share of Recombinant Antibody by Type in 2015
1.2.1 Type
1.2.2 Type
1.2.3 Type
1.3 Recombinant Antibody Market Segmentation by Application
1.3.1 Recombinant Antibody Consumption Market Share by Application in 2015
1.3.2 Application
1.3.3 Application
1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Recombinant Antibody (2011-2021)
CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON RECOMBINANT ANTIBODY INDUSTRY
2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend
CHAPTER 3 UNITED STATES RECOMBINANT ANTIBODY MARKET COMPETITION BY MANUFACTURERS
3.1 United States Recombinant Antibody Production and Share by Manufacturers (2015 and 2016)
3.2 United States Recombinant Antibody Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Recombinant Antibody Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Recombinant Antibody Manufacturing Base Distribution, Production Area and Product Type
3.5 Recombinant Antibody Market Competitive Situation and Trends
3.5.1 Recombinant Antibody Market Concentration Rate
3.5.2 Recombinant Antibody Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
CHAPTER 4 UNITED STATES RECOMBINANT ANTIBODY PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 United States Recombinant Antibody Production and Market Share by Type (2012-2017)
4.2 United States Recombinant Antibody Revenue and Market Share by Type (2012-2017)
4.3 United States Recombinant Antibody Price by Type (2012-2017)
4.4 United States Recombinant Antibody Production Growth by Type (2012-2017)
CHAPTER 5 UNITED STATES RECOMBINANT ANTIBODY MARKET ANALYSIS BY APPLICATION
5.1 United States Recombinant Antibody Consumption and Market Share by Application (2012-2017)
5.2 United States Recombinant Antibody Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
5.3.1 Potential Applications
5.3.2 Emerging Markets/Countries
CHAPTER 6 UNITED STATES RECOMBINANT ANTIBODY MANUFACTURERS ANALYSIS
6.1 A.G.Scientific
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Product Type, Application and Specification
6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Business Overview
6.2 Abbott Diagnostics
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Product Type, Application and Specification
6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Business Overview
6.3 Agilent Technologies
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Product Type, Application and Specification
6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Business Overview
6.4 BD Biosciences
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Product Type, Application and Specification
6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Business Overview
6.5 Beckman Coulter
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Product Type, Application and Specification
6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Business Overview
6.6 bioMerieux
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Business Overview
6.7 Bio-Rad Laboratories
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Product Type, Application and Specification
6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Business Overview
6.8 F. Hoffmann-La Roche
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Business Overview
6.9 Gallus Immunotech
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Product Type, Application and Specification
6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Business Overview
CHAPTER 7 RECOMBINANT ANTIBODY MANUFACTURING COST ANALYSIS
7.1 Recombinant Antibody Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Recombinant Antibody
CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Recombinant Antibody Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Recombinant Antibody Major Manufacturers in 2015
8.4 Downstream Buyers
CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
CHAPTER 11 UNITED STATES RECOMBINANT ANTIBODY MARKET FORECAST (2017-2021)
11.1 United States Recombinant Antibody Production, Revenue Forecast (2017-2021)
11.2 United States Recombinant Antibody Production, Consumption Forecast by Regions (2017-2021)
11.3 United States Recombinant Antibody Production Forecast by Type (2017-2021)
11.4 United States Recombinant Antibody Consumption Forecast by Application (2017-2021)
11.5 Recombinant Antibody Price Forecast (2017-2021)
CHAPTER 12 APPENDIX
1.1 Product Overview and Scope of Recombinant Antibody
1.2 Recombinant Antibody Market Segmentation by Type
1.2.1 United States Production Market Share of Recombinant Antibody by Type in 2015
1.2.1 Type
1.2.2 Type
1.2.3 Type
1.3 Recombinant Antibody Market Segmentation by Application
1.3.1 Recombinant Antibody Consumption Market Share by Application in 2015
1.3.2 Application
1.3.3 Application
1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Recombinant Antibody (2011-2021)
CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON RECOMBINANT ANTIBODY INDUSTRY
2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend
CHAPTER 3 UNITED STATES RECOMBINANT ANTIBODY MARKET COMPETITION BY MANUFACTURERS
3.1 United States Recombinant Antibody Production and Share by Manufacturers (2015 and 2016)
3.2 United States Recombinant Antibody Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Recombinant Antibody Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Recombinant Antibody Manufacturing Base Distribution, Production Area and Product Type
3.5 Recombinant Antibody Market Competitive Situation and Trends
3.5.1 Recombinant Antibody Market Concentration Rate
3.5.2 Recombinant Antibody Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
CHAPTER 4 UNITED STATES RECOMBINANT ANTIBODY PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 United States Recombinant Antibody Production and Market Share by Type (2012-2017)
4.2 United States Recombinant Antibody Revenue and Market Share by Type (2012-2017)
4.3 United States Recombinant Antibody Price by Type (2012-2017)
4.4 United States Recombinant Antibody Production Growth by Type (2012-2017)
CHAPTER 5 UNITED STATES RECOMBINANT ANTIBODY MARKET ANALYSIS BY APPLICATION
5.1 United States Recombinant Antibody Consumption and Market Share by Application (2012-2017)
5.2 United States Recombinant Antibody Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
5.3.1 Potential Applications
5.3.2 Emerging Markets/Countries
CHAPTER 6 UNITED STATES RECOMBINANT ANTIBODY MANUFACTURERS ANALYSIS
6.1 A.G.Scientific
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Product Type, Application and Specification
6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Business Overview
6.2 Abbott Diagnostics
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Product Type, Application and Specification
6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Business Overview
6.3 Agilent Technologies
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Product Type, Application and Specification
6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Business Overview
6.4 BD Biosciences
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Product Type, Application and Specification
6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Business Overview
6.5 Beckman Coulter
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Product Type, Application and Specification
6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Business Overview
6.6 bioMerieux
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Business Overview
6.7 Bio-Rad Laboratories
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Product Type, Application and Specification
6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Business Overview
6.8 F. Hoffmann-La Roche
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Business Overview
6.9 Gallus Immunotech
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Product Type, Application and Specification
6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Business Overview
CHAPTER 7 RECOMBINANT ANTIBODY MANUFACTURING COST ANALYSIS
7.1 Recombinant Antibody Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Recombinant Antibody
CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Recombinant Antibody Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Recombinant Antibody Major Manufacturers in 2015
8.4 Downstream Buyers
CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
CHAPTER 11 UNITED STATES RECOMBINANT ANTIBODY MARKET FORECAST (2017-2021)
11.1 United States Recombinant Antibody Production, Revenue Forecast (2017-2021)
11.2 United States Recombinant Antibody Production, Consumption Forecast by Regions (2017-2021)
11.3 United States Recombinant Antibody Production Forecast by Type (2017-2021)
11.4 United States Recombinant Antibody Consumption Forecast by Application (2017-2021)
11.5 Recombinant Antibody Price Forecast (2017-2021)
CHAPTER 12 APPENDIX
LIST OF TABLES AND FIGURES
Figure Picture of Recombinant Antibody
Table Classification of Recombinant Antibody
Figure United States Sales Market Share of Recombinant Antibody by Type in 2015
Table Application of Recombinant Antibody
Figure United States Sales Market Share of Recombinant Antibody by Application in 2015
Figure United States Recombinant Antibody Sales and Growth Rate (2011-2021)
Figure United States Recombinant Antibody Revenue and Growth Rate (2011-2021)
Table United States Recombinant Antibody Sales of Key Manufacturers (2015 and 2016)
Table United States Recombinant Antibody Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Recombinant Antibody Sales Share by Manufacturers
Figure 2016 Recombinant Antibody Sales Share by Manufacturers
Table United States Recombinant Antibody Revenue by Manufacturers (2015 and 2016)
Table United States Recombinant Antibody Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Recombinant Antibody Revenue Share by Manufacturers
Table 2016 United States Recombinant Antibody Revenue Share by Manufacturers
Table United States Market Recombinant Antibody Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Recombinant Antibody Average Price of Key Manufacturers in 2015
Figure Recombinant Antibody Market Share of Top 3 Manufacturers
Figure Recombinant Antibody Market Share of Top 5 Manufacturers
Table United States Recombinant Antibody Sales by Type (2012-2017)
Table United States Recombinant Antibody Sales Share by Type (2012-2017)
Figure United States Recombinant Antibody Sales Market Share by Type in 2015
Table United States Recombinant Antibody Revenue and Market Share by Type (2012-2017)
Table United States Recombinant Antibody Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Recombinant Antibody by Type (2012-2017)
Table United States Recombinant Antibody Price by Type (2012-2017)
Figure United States Recombinant Antibody Sales Growth Rate by Type (2012-2017)
Table United States Recombinant Antibody Sales by Application (2012-2017)
Table United States Recombinant Antibody Sales Market Share by Application (2012-2017)
Figure United States Recombinant Antibody Sales Market Share by Application in 2015
Table United States Recombinant Antibody Sales Growth Rate by Application (2012-2017)
Figure United States Recombinant Antibody Sales Growth Rate by Application (2012-2017)
Table A.G.Scientific Basic Information, Manufacturing Base, Production Area and Its Competitors
Table A.G.Scientific Recombinant Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table A.G.Scientific Recombinant Antibody Market Share (2012-2017)
Table Abbott Diagnostics Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Abbott Diagnostics Recombinant Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Diagnostics Recombinant Antibody Market Share (2012-2017)
Table Agilent Technologies Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Agilent Technologies Recombinant Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table Agilent Technologies Recombinant Antibody Market Share (2012-2017)
Table BD Biosciences Basic Information, Manufacturing Base, Production Area and Its Competitors
Table BD Biosciences Recombinant Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table BD Biosciences Recombinant Antibody Market Share (2012-2017)
Table Beckman Coulter Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Beckman Coulter Recombinant Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table Beckman Coulter Recombinant Antibody Market Share (2012-2017)
Table bioMerieux Basic Information, Manufacturing Base, Production Area and Its Competitors
Table bioMerieux Recombinant Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table bioMerieux Recombinant Antibody Market Share (2012-2017)
Table Bio-Rad Laboratories Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bio-Rad Laboratories Recombinant Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table Bio-Rad Laboratories Recombinant Antibody Market Share (2012-2017)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base, Production Area and Its Competitors
Table F. Hoffmann-La Roche Recombinant Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table F. Hoffmann-La Roche Recombinant Antibody Market Share (2012-2017)
Table Gallus Immunotech Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Gallus Immunotech Recombinant Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table Gallus Immunotech Recombinant Antibody Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Antibody
Figure Manufacturing Process Analysis of Recombinant Antibody
Figure Recombinant Antibody Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Antibody Major Manufacturers in 2015
Table Major Buyers of Recombinant Antibody
Table Distributors/Traders List
Figure United States Recombinant Antibody Production and Growth Rate Forecast (2017-2021)
Figure United States Recombinant Antibody Revenue and Growth Rate Forecast (2017-2021)
Table United States Recombinant Antibody Production Forecast by Type (2017-2021)
Table United States Recombinant Antibody Consumption Forecast by Application (2017-2021)
COMPANIES MENTIONED
A.G.Scientific
Abbott Diagnostics
Agilent Technologies
BD Biosciences
Beckman Coulter
bioMerieux
Bio-Rad Laboratories
F. Hoffmann-La Roche
Gallus Immunotech
GE Healthcare
Lonza Biologics Ltd
Merck KGaA
Meridian Life Science
Figure Picture of Recombinant Antibody
Table Classification of Recombinant Antibody
Figure United States Sales Market Share of Recombinant Antibody by Type in 2015
Table Application of Recombinant Antibody
Figure United States Sales Market Share of Recombinant Antibody by Application in 2015
Figure United States Recombinant Antibody Sales and Growth Rate (2011-2021)
Figure United States Recombinant Antibody Revenue and Growth Rate (2011-2021)
Table United States Recombinant Antibody Sales of Key Manufacturers (2015 and 2016)
Table United States Recombinant Antibody Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Recombinant Antibody Sales Share by Manufacturers
Figure 2016 Recombinant Antibody Sales Share by Manufacturers
Table United States Recombinant Antibody Revenue by Manufacturers (2015 and 2016)
Table United States Recombinant Antibody Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Recombinant Antibody Revenue Share by Manufacturers
Table 2016 United States Recombinant Antibody Revenue Share by Manufacturers
Table United States Market Recombinant Antibody Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Recombinant Antibody Average Price of Key Manufacturers in 2015
Figure Recombinant Antibody Market Share of Top 3 Manufacturers
Figure Recombinant Antibody Market Share of Top 5 Manufacturers
Table United States Recombinant Antibody Sales by Type (2012-2017)
Table United States Recombinant Antibody Sales Share by Type (2012-2017)
Figure United States Recombinant Antibody Sales Market Share by Type in 2015
Table United States Recombinant Antibody Revenue and Market Share by Type (2012-2017)
Table United States Recombinant Antibody Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Recombinant Antibody by Type (2012-2017)
Table United States Recombinant Antibody Price by Type (2012-2017)
Figure United States Recombinant Antibody Sales Growth Rate by Type (2012-2017)
Table United States Recombinant Antibody Sales by Application (2012-2017)
Table United States Recombinant Antibody Sales Market Share by Application (2012-2017)
Figure United States Recombinant Antibody Sales Market Share by Application in 2015
Table United States Recombinant Antibody Sales Growth Rate by Application (2012-2017)
Figure United States Recombinant Antibody Sales Growth Rate by Application (2012-2017)
Table A.G.Scientific Basic Information, Manufacturing Base, Production Area and Its Competitors
Table A.G.Scientific Recombinant Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table A.G.Scientific Recombinant Antibody Market Share (2012-2017)
Table Abbott Diagnostics Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Abbott Diagnostics Recombinant Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Diagnostics Recombinant Antibody Market Share (2012-2017)
Table Agilent Technologies Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Agilent Technologies Recombinant Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table Agilent Technologies Recombinant Antibody Market Share (2012-2017)
Table BD Biosciences Basic Information, Manufacturing Base, Production Area and Its Competitors
Table BD Biosciences Recombinant Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table BD Biosciences Recombinant Antibody Market Share (2012-2017)
Table Beckman Coulter Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Beckman Coulter Recombinant Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table Beckman Coulter Recombinant Antibody Market Share (2012-2017)
Table bioMerieux Basic Information, Manufacturing Base, Production Area and Its Competitors
Table bioMerieux Recombinant Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table bioMerieux Recombinant Antibody Market Share (2012-2017)
Table Bio-Rad Laboratories Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bio-Rad Laboratories Recombinant Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table Bio-Rad Laboratories Recombinant Antibody Market Share (2012-2017)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base, Production Area and Its Competitors
Table F. Hoffmann-La Roche Recombinant Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table F. Hoffmann-La Roche Recombinant Antibody Market Share (2012-2017)
Table Gallus Immunotech Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Gallus Immunotech Recombinant Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table Gallus Immunotech Recombinant Antibody Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Antibody
Figure Manufacturing Process Analysis of Recombinant Antibody
Figure Recombinant Antibody Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Antibody Major Manufacturers in 2015
Table Major Buyers of Recombinant Antibody
Table Distributors/Traders List
Figure United States Recombinant Antibody Production and Growth Rate Forecast (2017-2021)
Figure United States Recombinant Antibody Revenue and Growth Rate Forecast (2017-2021)
Table United States Recombinant Antibody Production Forecast by Type (2017-2021)
Table United States Recombinant Antibody Consumption Forecast by Application (2017-2021)
COMPANIES MENTIONED
A.G.Scientific
Abbott Diagnostics
Agilent Technologies
BD Biosciences
Beckman Coulter
bioMerieux
Bio-Rad Laboratories
F. Hoffmann-La Roche
Gallus Immunotech
GE Healthcare
Lonza Biologics Ltd
Merck KGaA
Meridian Life Science
